The STEP 1 trial showed weight loss continuing from this point until approximately week 60, when average loss reached 14.9 percent of body weight
Lifestyle Factors While semaglutide plays a significant role in helping individuals manage weight and improve metabolic health, the results it delivers are greatly influenced by lifestyle factors
The SUSTAIN and PIONEER trial series, along with the SELECT trial, represent thousands of patient-years of safety monitoring
Choosing between tirzepatide and semaglutide depends on several factors, including weight loss goals, medical history, tolerance for side effects, and access to care
In native GLP-1, this position holds an alanine residue, and it is exactly where DPP-4 attacks
The accelerated approval timeline is notable, but the real story is the dose-response validation in STEP UP